Continuous glucose monitoring during pregnancy complicated by gestational diabetes mellitus.

被引:15
作者
Jovanovic L. [1 ]
机构
[1] Sansum Medical Research Institute, 2219 Bath Street, Santa Barbara, 93105, CA
关键词
Gestational Diabetes Mellitus; Gestational Diabetes; Glucose Monitoring; Postprandial Glucose; Continuous Glucose Monitoring;
D O I
10.1007/s11892-001-0015-9
中图分类号
学科分类号
摘要
Postprandial glucose has been reported to be the best predictor of neonatal macrosomia. Therefore, self-blood glucose monitoring (SBGM) protocols for diabetic pregnant women stress the importance of measuring blood glucose after meals. However, there is controversy in the literature. Traditionally, glucose monitoring has been prescribed at 2 hours after eating to coincide with the times a patient is at increased risk of hypoglycemia. Human regular insulin peaks at 2 to 3 hours after injection; thus, checking blood glucose at the 2-hour point is a relic of strategies to prevent hypoglycemia. In pregnancy, the emphasis has been on measuring during times when blood glucose levels are highest. One hour after the start of the meal has been shown to be the time of peak postprandial response in 90% of pregnant woman. Because glucose excursions may reach their maximum at varying times, based on the size and number of meals ingested, SBGM alone may not capture the full extent of total daily postprandial hyperglycemia. Because intermittent blood glucose monitoring underestimates the number of hyperglycemic events, a more accurate determination of postprandial glucose levels is necessary to decrease the risk of macrosomia in gestational diabetes mellitus. Continuous glucose monitoring may facilitate the detection of all postprandial peaks, including those due to unscheduled meals, and may provide an opportunity for better intervention by providing the complete glucose profile.
引用
收藏
页码:82 / 85
页数:3
相关论文
共 78 条
[1]  
Engelgau M(1995)The epidemiology of diabetes and pregnancy in the US, 1988 Diabetes Care 18 1029-1033
[2]  
German R(1994)Birth weight and non-insulin-dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? BMJ 398 942-945
[3]  
Herman W(1988)The relationship between large-for-gestational- age infants and glycemic control in women with gestational diabetes Am J Obstet Gynecol 159 1478-1483
[4]  
McCance DR(1998)Neonatal morbidities in gestational diabetes mellitus Diabetes Care 21 B79-B84
[5]  
Pettitt DJ(1993)Magnetic resonance imaging in pregnancies complicated by diabetes predicts infant birthweight ratio and neonatal morbidity Am J Perinatol 10 432-437
[6]  
Hanson RL(1997)The Santa Barbara County Health Care Services Program: birth weight change concomitant with screening for and treatment of glucoseintolerance of pregnancy: a potential cost-effective intervention Am J Perinatol 14 221-228
[7]  
Langer O(2000)Glycemic control in the diabetic pregnancy: is tighter always better? J Matern Fetal Med 9 29-34
[8]  
Mazze R(1995)Gestational diabetes mellitus: is it a clinical entity? Diabetes Rev 3 603-613
[9]  
Persson B(1995)Perinatal morbidity in offspring of diabetic mothers Diabetes Rev 3 652-657
[10]  
Hanson U(1995)Is normoglycemia the correct threshold to prevent complications in the pregnant diabetic patient? Diabetes Rev 4 2-10